Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel in Social Phobia
NCT00773162Phase 3Completed
- Sponsor
- START Clinic for Mood and Anxiety Disorders
- Start
- Oct 2008
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quetiapine (extended-release tablet, brand name: Bipresso) in Social Anxiety Disorder (SAD) (2 arms), sponsored by START Clinic for Mood and Anxiety Disorders. Primary endpoint: Changes in intensity of the vasodilatory response to 10 mM topical methyl-nicotinate at 20 weeks. Started Oct 2008; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00773162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773162.